Clinical Trial Update: The Budesonide in Babies (BiB) Trial [Phase 3]

View source ↗

Summary

Phase 3 results from the Budesonide in Babies (BiB) trial are posted; the study in preterm infants targeting bronchopulmonary dysplasia is now non-recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Respiratory Distress Syndrome

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Bronchopulmonary Dysplasia (BPD), Respiratory Distress Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-11-10